Login / Signup

Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by GONO Foundation.

Sara LonardiCosimo RasolaRiccardo LobefaroDaniele RossiniVincenzo FormicaMario ScartozziGiovanni Luca FrassinetiGiorgia BoscoloSaverio CinieriSamantha Di DonatoNicoletta PellaFrancesca BergamoAlessandra RaimondiErmenegildo ArnoldiLorenzo AntonuzzoCristina GranettoFable ZustovichMonica RonzoniSilvana LeoFederica MoranoFotios LoupakisFederica BugginVittorina ZagonelAngelo Paolo Dei TosChiara CremoliniLuca BoniFilippo Pietrantonionull null
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
wild-type mCRC. 5-FU + LV + PAN is associated with a better safety profile.
Keyphrases
  • wild type
  • metastatic colorectal cancer
  • study protocol
  • phase iii
  • clinical trial
  • middle aged
  • phase ii
  • community dwelling